Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor

1dos Santos Silva I. Cancer epidemiology: principles and methods. Lyon France: World Health Organization. International Agency for Research on Cancer; 1999. p. 385-403.dos Santos Silva I Cancer epidemiology: principles and methods Lyon France: World Health Organization. International Agency for Research on Cancer; 1999 385–403Search in Google Scholar

2Institute of Oncology Ljubljana. Cancer Registry of Republic of Slovenia and other registries. [cited 2021 Sep 15]. Available at https://www.onko-i.si/eng/sectors/epidemiology-and-cancer-registryInstitute of Oncology Ljubljana Cancer Registry of Republic of Slovenia and other registries [cited 2021 Sep 15]. Available at https://www.onko-i.si/eng/sectors/epidemiology-and-cancer-registrySearch in Google Scholar

3Zadnik V, Žagar T, Lokar K, Tomšič, Duratović Konjević A, Bric N, et al. [Survival of cancer patients in Slovenia.] [Slovenian]. Onkologija 2021; 25: 42-7. doi: 10.25670/oi2021-004onZadnik V Žagar T Lokar K Tomšič Duratović Konjević A Bric N et al [Survival of cancer patients in Slovenia.] [Slovenian] Onkologija 2021 25 42 7 10.25670/oi2021-004onOpen DOISearch in Google Scholar

4Zakotnik B. Tomšič S. [National Cancer Control Plan – achievments and challenges]. [Slovenian]. Onkologija 2021; 25: 60-6. doi: 10.25670/oi2021010onZakotnik B Tomšič S [National Cancer Control Plan – achievments and challenges]. [Slovenian]. Onkologija 2021 25 60 6 10.25670/oi2021010onOpen DOISearch in Google Scholar

5Hočevar M. [Clinical registry in oncology]. [Slovenian]. Onkologija 2011; 15: 14-7. [cited 2021 Aug 15]. Available at http://www.dlib.si/?URN=URN:NBN:SI:doc-YC5I34R6Hočevar M [Clinical registry in oncology]. [Slovenian] Onkologija 2011 15 14 7 [cited 2021 Aug 15]. Available athttp://www.dlib.si/?URN=URN:NBN:SI:doc-YC5I34R6Search in Google Scholar

6Takač I, Ferletič M, Arko D, Gorišek B. [Follow-up computer program for patients with ovarian malignancy]. [Slovenian]. Bigec M, Lavrenčič D, Kokol P, editors. Proceedings part II. Inform Med Slov 1996; 3: 43-6.Takač I Ferletič M Arko D Gorišek B [Follow-up computer program for patients with ovarian malignancy] [Slovenian]. Bigec M, Lavrenčič D, Kokol P, editors. Proceedings part II. Inform Med Slov 1996 3 43 6Search in Google Scholar

7Takač I, Gorišek B. User friendly inquiry and computer program for following patients with ovarian malignancy. Arch Gynecol Obstet 1999; 263: 60-7. doi: 10.1007/s004040050264Takač I Gorišek B User friendly inquiry and computer program for following patients with ovarian malignancy Arch Gynecol Obstet 1999 263 60 7 10.1007/s00404005026410728632Open DOISearch in Google Scholar

8Arko D, Takač I. Inquiry and computer program Onko-Online: 25 years of clinical registry for breast cancer at the University Medical Centre Maribor. Radiol Oncol 2019; 53: 348-56. doi: 10.2478/raon-2019-0043Arko D Takač I Inquiry and computer program Onko-Online: 25 years of clinical registry for breast cancer at the University Medical Centre Maribor Radiol Oncol 2019 53 348 56 10.2478/raon-2019-0043676515631553707Open DOISearch in Google Scholar

9Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359: 1093-101. doi: 10.1016/S0140-6736(02)08151-5Muñoz N Franceschi S Bosetti C Moreno V Herrero R Smith JS et al Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 2002 359 1093 101 10.1016/S0140-6736(02)08151-511943256Open DOISearch in Google Scholar

10The International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007; 120: 885-91. doi: 10.1002/ijc.22357The International Collaboration of Epidemiological Studies of Cervical Cancer Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies Int J Cancer 2007 120 885 91 10.1002/ijc.2235717131323Open DOISearch in Google Scholar

11Lea JS, Lin KY. Cervical Cancer. Obstet Gynecol Clin N Am 2012; 39: 233-53. doi: 10.1016/j.ogc.2012.02.008Lea JS Lin KY Cervical Cancer Obstet Gynecol Clin N Am 2012 39 233 53 10.1016/j.ogc.2012.02.00822640713Open DOISearch in Google Scholar

12Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 2005; 105: 174-81. doi: 10.1097/01.AOG.0000148268.43584.03Trimble CL Genkinger JM Burke AE Hoffman SC Helzlsouer KJ Diener-West M et al Active and passive cigarette smoking and the risk of cervical neoplasia Obstet Gynecol 2005 105 174 81 10.1097/01.AOG.0000148268.43584.03306498715625160Open DOISearch in Google Scholar

13Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol study. Lancet 2002; 359: 1085-92. doi: 10.1016/S0140-6736(02)08150-3Moreno V Bosch FX Muñoz N Meijer CJ Shah KV Walboomers JM et al Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol study Lancet 2002 359 1085 92 10.1016/S0140-6736(02)08150-311943255Open DOISearch in Google Scholar

14Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer 2006; 106: 664-9. doi: 10.1002/cncr.21660Datta GD Colditz GA Kawachi I Subramanian SV Palmer JR Rosenberg L Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S black women: a multilevel analysis. Cancer 2006 106 664 9 10.1002/cncr.2166016378349Open DOISearch in Google Scholar

15Kesic V, Poljak M, Rogovskaya S. Cervical cancer burden and prevention activities in Europe. Cancer Epidemiol Biomarkers Prev 2012; 21: 1423-33. doi: 10.1158/1055-9965.EPI-12-0181Kesic V Poljak M Rogovskaya S Cervical cancer burden and prevention activities in Europe Cancer Epidemiol Biomarkers Prev 2012 21 1423 33 10.1158/1055-9965.EPI-12-018122956728Open DOISearch in Google Scholar

16Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control 2009; 20: 1129-38. doi: 10.1007/s10552-009-9317-zBarnholtz-Sloan J Patel N Rollison D Kortepeter K MacKinnon J Giuliano A Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity Cancer Causes Control 2009 20 1129 38 10.1007/s10552-009-9317-z19253025Open DOISearch in Google Scholar

17Gutnik H, Kastelic P, Oštrbenk Valenčak A, Poljak M, Strojan Fležar M. Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features. Virchows Archiv 2020; 476: 25160. doi: 10.1007/s00428-019-02694-7Gutnik H Kastelic P Oštrbenk Valenčak A Poljak M Strojan Fležar M Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features Virchows Archiv 2020 476 25160 10.1007/s00428-019-02694-731754816Open DOISearch in Google Scholar

18Škamperle M, Kocjan BJ, Maver PJ, Seme K, Poljak M. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe. Acta Dermatovenerol Pannonica Adriat 2013; 22: 1-5. doi: 10.2478/v10162-012-0024-1Škamperle M Kocjan BJ Maver PJ Seme K Poljak M Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe Acta Dermatovenerol Pannonica Adriat 2013 22 1 5 10.2478/v10162-012-0024-1Open DOISearch in Google Scholar

19Arbyn M, Gultekin M, Morice P, Nieminen P, Cruickshank M, Poortmans P, et al. The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer 2021; 148: 277-84. doi: 10.1002/ijc.33189Arbyn M Gultekin M Morice P Nieminen P Cruickshank M Poortmans P et al The European response to the WHO call to eliminate cervical cancer as a public health problem Int J Cancer 2021 148 277 84 10.1002/ijc.33189775440032638362Open DOISearch in Google Scholar

20Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. doi: 10.1515/raon-2017-0008Zadnik V Primic Zakelj M Lokar K Jarm K Ivanus U Zagar T Cancer burden in Slovenia with the time trends analysis Radiol Oncol 2017 51 47 55 10.1515/raon-2017-0008533017428265232Open DOISearch in Google Scholar

21Zadnik V, Žagar T. SLORA: Slovenia and cancer. Epidemiology and Cancer Registry. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana. [2021 Feb 14]. Available at: www.slora.siZadnik V Žagar T SLORA: Slovenia and cancer. Epidemiology and Cancer Registry. [Slovenian] Ljubljana Institute of Oncology Ljubljana [2021 Feb 14]. Available at www.slora.siSearch in Google Scholar

22Lim AWW, Forbes LJL, Rosenthal AN, Raju KS, Ramirez AJ. Measuring the nature and duration of symptoms of cervical cancer in young women: developing an interview-based approach. BMC Womens Health 2013; 13: 45. doi: 10.1186/1472-6874-13-45Lim AWW Forbes LJL Rosenthal AN Raju KS Ramirez AJ Measuring the nature and duration of symptoms of cervical cancer in young women: developing an interview-based approach BMC Womens Health 2013 13 45 10.1186/1472-6874-13-45383539524219028Open DOISearch in Google Scholar

23Ursic-Vrscaj M, Rakar S, Mozina A, Takac I, Bebar S, Subic Z, et al. Clinical audit of patients with cervical cancer in Slovenia. Data analysis from 20032006. Eur J Gynaecol Oncol 2008; 29: 628-2. PMID: 19115692Ursic-Vrscaj M Rakar S Mozina A Takac I Bebar S Subic Z et al Clinical audit of patients with cervical cancer in Slovenia Data analysis from 20032006. Eur J Gynaecol Oncol 2008 29 628 2 PMID: 19115692Search in Google Scholar

24Ursic-Vrscaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger I, et al. [Guidelines for management of women with cervical precancerous lesions]. [Slovenian]. In: Ursic-Vrscaj M, editor. Ljubljana: Institute of Oncology Ljubljana; 2011Ursic-Vrscaj M Rakar S Možina A Kobal B Takač I Deisinger I et al [Guidelines for management of women with cervical precancerous lesions] [Slovenian]. In: Ursic-Vrscaj M, editor. Ljubljana: Institute of Oncology Ljubljana; 2011Search in Google Scholar

25Ivanuš U. Colposcopy in the ZORA program. [Slovenian]. In: Smrkolj Š, editor. Refresing colposcopic course. Proceedings. Ljubljana: Association for Gynecologic Oncology, Colposcopy and Cervical Pathology, Slovenian Medical Association, Institute of Oncology Ljubljana; 2019. p. 30-49.Ivanuš U Colposcopy in the ZORA program [Slovenian]. In: Smrkolj Š, editor. Refresing colposcopic course. Proceedings. Ljubljana: Association for Gynecologic Oncology, Colposcopy and Cervical Pathology, Slovenian Medical Association, Institute of Oncology Ljubljana; 2019 30–49Search in Google Scholar

26Učakar V, Poljak M, Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 2012; 30: 116-20. doi: 10.1016/j.vaccine.2011.10.066Učakar V Poljak M Klavs I Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study Vaccine 2012 30 116 20 10.1016/j.vaccine.2011.10.06622080175Open DOISearch in Google Scholar

27Vrtačnik Bokal E, Kocjan BJ, Poljak M, Bogovac Ž, Jančar N. Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J Obstet Gynaecol Res 2010; 36: 1204-13. doi: 10.1111/j.1447-0756.2010.01316.xVrtačnik Bokal E Kocjan BJ Poljak M Bogovac Ž, Jančar N Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia J Obstet Gynaecol Res 2010 36 1204 13 10.1111/j.1447-0756.2010.01316.x21114573Open DOISearch in Google Scholar

28Ivanus U, Jerman T, Repse Fokter A, Takac I, Kloboves Prevodnik V, Marcec M, et al. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiol Oncol 2018; 52: 399-412. doi: 10.2478/raon-2018-0036Ivanus U Jerman T Repse Fokter A Takac I Kloboves Prevodnik V Marcec M et al Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches Radiol Oncol 2018 52 399 412 10.2478/raon-2018-0036628718330216191Open DOISearch in Google Scholar

29Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009; 105: 107-8. doi: 10.1016/j.ijgo.2009.02.009Pecorelli S Zigliani L Odicino F Revised FIGO staging for carcinoma of the cervix Int J Gynaecol Obstet 2009 105 107 8 10.1016/j.ijgo.2009.02.00919342051Open DOISearch in Google Scholar

30Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019; 145: 129-35. doi: 10.1002/ijgo.12749Bhatla N Berek JS Cuello Fredes M Denny LA Grenman S Karunaratne K et al Revised FIGO staging for carcinoma of the cervix uteri Int J Gynaecol Obstet 2019 145 129 35 10.1002/ijgo.1274930656645Open DOISearch in Google Scholar

31Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991; 20: 667-76. doi: 10.1016/0360-3016(91)90007-qLanciano RM Won M Coia LR Hanks GE Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies Int J Radiat Oncol Biol Phys 1991 20 667 76 10.1016/0360-3016(91)90007-q2004942Open DOISearch in Google Scholar

32Espenel S, Garcia MA, Langrand-Escure J, Vallard A, Chloé Trone J, Rancoule C, et al. Special focus on stage IV cervical cancer patients: a decade experience. Oncology 2019; 97: 125-34. doi: 10.1159/000500025Espenel S Garcia MA Langrand-Escure J Vallard A Chloé Trone J Rancoule C et al Special focus on stage IV cervical cancer patients: a decade experience Oncology 2019 97 125 34 10.1159/00050002531266037Open DOISearch in Google Scholar

33Hallquist Everhov Å, Nyberg T, Bergmark K, Citarella A, Flöter Rådestad A, Lindén Hirschberg A, et al. Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study. Menopause 2015; 22: 633-9. doi: 10.1097/GME.0000000000000357Hallquist Everhov Å Nyberg T Bergmark K Citarella A Flöter Rådestad A Lindén Hirschberg A et al Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study Menopause 2015 22 633 9 10.1097/GME.000000000000035725405572Open DOISearch in Google Scholar

34Stolnicu S, Hoang L, Soslow RA. Recent advances in invasive adenocarcinoma of the cervix. Virchows Arch 2019; 475: 537-49. doi: 10.1007/s00428-019-02601-0Stolnicu S Hoang L Soslow RA Recent advances in invasive adenocarcinoma of the cervix Virchows Arch 2019 475 537 49 10.1007/s00428-019-02601-0686426531209635Open DOISearch in Google Scholar

35Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, et al. International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 2018; 42: 214-26. doi: 10.1097/PAS.0000000000000986Stolnicu S Barsan I Hoang L Patel P Terinte C Pesci A et al International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix Am J Surg Pathol 2018 42 214 26 10.1097/PAS.0000000000000986576225829135516Open DOISearch in Google Scholar

36Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, et al. Cervical cancer: screening, diagnosis and staging. J BUON 2016; 21: 320-5. PMID: 27273940Tsikouras P Zervoudis S Manav B Tomara E Iatrakis G Romanidis C et al Cervical cancer: screening, diagnosis and staging J BUON 2016 21 320 5 PMID: 27273940Search in Google Scholar

37Copeland LJ, Silva EG, Gershenson DM, Morris M, Young DC, Wharton JT. Super-ficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992; 45: 307-12. doi: 10.1016/0090-8258(92)90310-fCopeland LJ Silva EG Gershenson DM Morris M Young DC Wharton JT Super-ficially invasive squamous cell carcinoma of the cervix Gynecol Oncol 1992 45 307 12 10.1016/0090-8258(92)90310-f1612508Open DOISearch in Google Scholar

38Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology / European Society for Radiotherapy and Oncology / European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol 2018; 127: 404-16. doi: 10.1016/j.radonc.2018.03.003Cibula D Pötter R Planchamp F Avall-Lundqvist E Fischerova D Haie Meder C et al The European Society of Gynaecological Oncology / European Society for Radiotherapy and Oncology / European Society of Pathology guidelines for the management of patients with cervical cancer Radiother Oncol 2018 127 404 16 10.1016/j.radonc.2018.03.00329728273Open DOISearch in Google Scholar

39McCluggage WG, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, et al. Cervical carcinoma histopathology reporting guide. 3rd edition. Sydney, Australia: International Collaboration on Cancer Reporting; 2020. ISBN: 978-1-922324-00-9.McCluggage WG Alvarado-Cabrero I Duggan MA Horn LC Hui P Ordi J et al Cervical carcinoma histopathology reporting guide. 3rd edition Sydney, Australia: International Collaboration on Cancer Reporting; 2020 ISBN: 978-1-922324-00-9Search in Google Scholar

40Kern I, Strojan Fležar M, Kavalar R, Repše Fokter A, Balažic J, Frković Grazio S. [Guidelines for standardization of procedures and histopathological findings in the field of gynecological pathology ‒ cervical neoplasia]. [Slovenian]. Strojan Fležar M, Frković Grazio S, Gutnik H, editors. Ljubljana: Association for Pathology and Forensic Medicine, Slovenian Medical Association; 2015. [cited 2021 Jul 15]. Available at: https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/HISTO_smernice_ZPSM-SM-GIN-01_nov2015.pdfKern I Strojan Fležar M Kavalar R Repše Fokter A Balažic J Frković Grazio S [Guidelines for standardization of procedures and histopathological findings in the field of gynecological pathology ‒ cervical neoplasia] [Slovenian]. Strojan Fležar M, Frković Grazio S, Gutnik H, editors. Ljubljana: Association for Pathology and Forensic Medicine, Slovenian Medical Association; 2015 [cited 2021 Jul 15]. Available at https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/HISTO_smernice_ZPSM-SM-GIN-01_nov2015.pdfSearch in Google Scholar

41Šegedin B, Sebastjan Merlo S, Arko D, Bebar S, Cerar O, Cvjetićanin B, et al. [Recommendations for the treatment of patients with cervical cancer]. [Slovenian]. In: Šegedin B, Merlo S, editors. Ljubljana: National Program ZORA, Association for Radiotherapy and Oncology, Section for Internal Medicine Oncology, Association fo r Gynecological Oncology, Colposcopy and Cervical Pathology, Slovenian Medical Association, Institute of Oncology Ljubljana; 2019Šegedin B Sebastjan Merlo S Arko D Bebar S Cerar O Cvjetićanin B et al [Recommendations for the treatment of patients with cervical cancer] [Slovenian]. In: Šegedin B, Merlo S, editors. Ljubljana: National Program ZORA, Association for Radiotherapy and Oncology, Section for Internal Medicine Oncology, Association fo r Gynecological Oncology, Colposcopy and Cervical Pathology, Slovenian Medical Association, Institute of Oncology Ljubljana; 2019Search in Google Scholar

42Bielska-Lasota M, Rossi S, Krzyżak M, Haelens A, Domenic A, De Angelis R, et al. EUROCARE-5 Working Group. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet 2020; 301: 591-602. doi: 10.1007/s00404-019-05412-5Bielska-Lasota M Rossi S Krzyżak M Haelens A Domenic A De Angelis R et al EUROCARE-5 Working Group Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet 2020 301 591 602 10.1007/s00404-019-05412-531853712Open DOISearch in Google Scholar

43Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol 2009; 114: 528-35. doi: 10.1016/j.ygyno.2009.06.001Elit L Fyles AW Devries MC Oliver TK Fung-Kee-Fung M Follow-up for women after treatment for cervical cancer: a systematic review Gynecol Oncol 2009 114 528 35 10.1016/j.ygyno.2009.06.00119560188Open DOISearch in Google Scholar

44European Medicines Agency. The Cross-Committee Task Force on Patient Registries. Discussion paper: Use of patient disease registries for regulatory purposes – methodological and operational considerations. 5 November 2018. EMA/763513/2018European Medicines Agency The Cross-Committee Task Force on Patient Registries Discussion paper: Use of patient disease registries for regulatory purposes – methodological and operational considerations. 5 November 2018 EMA/763513/2018Search in Google Scholar

45Wordl Health Organization. Cervical Cancer Elimemination Initiative. [cited 2021 Jun 15]. Available at: https://www.who.int/initiatives/cervical-cancer-elimination-initiativeWordl Health Organization Cervical Cancer Elimemination Initiative [cited 2021 Jun 15]. Available at https://www.who.int/initiatives/cervical-cancer-elimination-initiativeSearch in Google Scholar